Eosinophils in COPD: just another biomarker?

Eosinophils in COPD: just another biomarker?

Eosinophils are innate immune cells that, under certain conditions, can be recruited to the lungs, where they have an incompletely understood role in health and disease. Eosinophils have been found in the airways, tissues, and circulation of patients with COPD, during both stable disease and exacerb...

Полное описание

Библиографические подробности
Главные авторы:	Bafadhel, M, Pavord, I, Russell, R
Формат:	Journal article
Язык:	English
Опубликовано:	Elsevier 2017

Схожие документы

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
по: Russell, R, и др.
Опубликовано: (2016)

Characterising non-eosinophilic COPD
по: Hambleton, K, и др.
Опубликовано: (2015)

Investigating blood eosinophil count thresholds in patients with COPD
по: Russell, R, и др.
Опубликовано: (2018)

Blood eosinophil levels as a biomarker in COPD
по: Brusselle, G, и др.
Опубликовано: (2018)

Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
по: Barker, R, и др.
Опубликовано: (2017)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
по: Shrimanker, R, и др.
Опубликовано: (2017)

Mepolizumab for eosinophilic COPD
по: Sciurba, F, и др.
Опубликовано: (2018)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
по: Bafadhel, M, и др.
Опубликовано: (2014)

Peripheral blood eosinophil drop-to-drop variation in patients with COPD using near patient testing: a small validation study
по: Jeffers, H, и др.
Опубликовано: (2017)

The significance of eosinophilic inflammation in COPD
по: Cooper, C, и др.
Опубликовано: (2017)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
по: Djamin, R, и др.
Опубликовано: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
по: Siddiqui, S, и др.
Опубликовано: (2018)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
по: Bafadhel, M, и др.
Опубликовано: (2016)

Biomarkers in COPD
по: Ramakrishnan, S, и др.
Опубликовано: (2021)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
по: Siddiqui SH, и др.
Опубликовано: (2018-11-01)

Eosinophil migration is enhanced towards IL-5 and eotaxin in COPD
по: Lababidi, R, и др.
Опубликовано: (2017)

Case series of long-term macrolide therapy effect on eosinophil count in COPD
по: Asciak, R, и др.
Опубликовано: (2017)

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
по: Helen F. Ashdown, и др.
Опубликовано: (2021-02-01)

Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
по: Hambleton, K, и др.
Опубликовано: (2016)

Blood eosinophil count and exacerbation risk in patients with COPD.
по: Kerkhof, M, и др.
Опубликовано: (2017)

Inhaled glucocorticoids and COPD exacerbations.
по: Brightling, C, и др.
Опубликовано: (2015)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
по: Bafadhel, M, и др.
Опубликовано: (2018)

Sputum Il-17a levels correlate with biomarkers of non-eosinophilic inflammation in patients with asthma
по: Hynes, G, и др.
Опубликовано: (2017)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
по: Russell, R, и др.
Опубликовано: (2019)

Just another diabetic
по: Rubayet Arefin
Опубликовано: (2019-11-01)

Just another chalazion?
по: Jonathan McLaughlin, и др.
Опубликовано: (2019-01-01)

Not just another genome
по: Tautz Diethard
Опубликовано: (2011-02-01)

Blood eosinophil count as a prognostic biomarker in COPD
по: Oh YM, и др.
Опубликовано: (2018-10-01)

The association between blood eosinophils and risk and treatment outcome in COPD is not dichotomised
по: Pascoe, S, и др.
Опубликовано: (2018)

Biomarkers for severe eosinophilic asthma.
по: Yancey, S, и др.
Опубликовано: (2017)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
по: Eltboli, O, и др.
Опубликовано: (2014)

Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO
по: Camp, J, и др.
Опубликовано: (2018)

Doxofylline is not just another theophylline!
по: Matera MG, и др.
Опубликовано: (2017-12-01)

Are blood eosinophils a prime-time biomarker for COPD management decisions?
по: Tsiligianni I, и др.
Опубликовано: (2018-06-01)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
по: Russell REK, и др.
Опубликовано: (2019-05-01)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
по: Kerkhof, M, и др.
Опубликовано: (2017)

Are COPD and cardiovascular disease fundamentally intertwined?
по: Bafadhel, M, и др.
Опубликовано: (2016)

Not Just Another Pretty Picture
по: Hilary Davis
Опубликовано: (2009-11-01)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function
по: Chapman, K, и др.
Опубликовано: (2018)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
по: James Camp, и др.
Опубликовано: (2018-09-01)